Regent Pacific expects US$0.5 million-US$1 million profit for six months ended June 30, 2026

• Regent Pacific forecast profit of US$0.5 million to US$1 million for the six months ended June 30, 2026.
• Guidance compares with a loss of US$2.22 million in the year-earlier period.
• Outlook driven by US$4.5 million net milestone income tied to New Drug Application approval for Senstend, cash due in H2 2026.
• Partly offset by about US$1 million impairment on a right-of-use asset for its Hong Kong office lease.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regent Pacific Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260803-12268182), on August 03, 2026, and is solely responsible for the information contained therein.